Effect of obesity on the response to insulin therapy in noninsulin- dependent diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 12, 1997, Pages 4037-4043

  Yki Järvinen, Hannele ^a   Ryysy, Leena ^b   Kauppila, Marjut ^c   Kujansuu, Eila ^d   Lahti, Jorma ^f   Marjanen, Tapani ^g   Niskanen, Leo ^f   Rajala, Sulo ^d   Salo, Seppo ^e   Seppälä, Pentti ^c   Tulokas, Timo ^h   Viikari, Jorma ^c   Taskinen, Marja Riitta ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KYMENLAAKSO CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d Hatanpää Hospital   (Finland)

^e Finnish Diabetes Association   (Finland)

^f Kuopio Municipal Hospital   (Finland)

^g Geriatrics Social and Welfare Health Center of Äanekoski   (Finland)

^h LAPLAND CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ISOPHANE INSULIN; NEUTRAL INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 9844269567     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.12.4460     Document Type: Article

References (22)

1. Pugh JA, Wagner ML, Sawyer J, Ramirez G, Tuley M, Friedberg SJ. 1992 Is combination sulfonylurea and insulin therapy useful in NIDDM patients? Diabetes Care. 15:953-959.
2. Yki-Järvinen H, Kauppila M, Kujansuu E, et al. 1992 Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 327:1426-1433.
3. Landstedt-Hallin L, Adamson U, Arner P, Bolinder J, Lins P-E. 1995 Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure. Diabetes Care. 18:1183-1186.
4. Chow C-C, Tsang LWW, Sorensen JP, Cockram CS. 1995 Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients. Diabetes Care. 18:307-314.
5. Bennett PH, Bogardus C, Tuomilehto J, Zimmet P. 1992 Epidemiology, and natural history of NIDDM: non-obese and obese. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, eds. International textbook of diabetes mellitus. New York: Wiley and Sons; 147-196.
6. Fassberg J. Toffler WL, Fields SA, Loriaux LD. 1993 Failure of insulin treatment in obese patients with non-insulin-dependent diabetes mellitus. J Fam Pract. 37:76-81.
7. Taves DR. 1974 Minimisation: a new method of assessing patients to treatment and control groups. Clin Pharmacol Ther. 15:443-453.
8. Stenman U-H, Pesonen K, Ylinen K, Huhtala ML, Teramo K. 1984 Rapid chromatographic quantitation of glycosylated haemoglobins. J Chromatogr. 297:327-332.
9. Kuzuya H, Blix PM, Horwitz DL, Steiner DF, Rubenstein AH. 1977 Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes. 26:22-29.
10. Taskinen M-R, Kuusi T, Helve E, Nikkilä E, Yki-Järvinen H. 1988 Insulin therapy induces antiathrogenic changes in serum lipoproteins in non-insulin-dependent diabetes mellitus. Arteriosclerosis 8:168-177.
11. Dixon WJ. 1981 BMDP Statistical software. Berkeley: University of California Press.
12. U.K. Prospective Diabetes Study Group. 1995 U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes. 44:1249-1258.
13. Yki-Järvinen H, Nikkilä K, Ryysy L, Tulokas T, Vanamo R, Heikkilä M. 1996 Comparison of bedtime insulin regimens in NIDDM: metformin prevents insulin-induced weight gain. Diabetologia. 39:A33.
14. Peacock I, Tattersall RB. 1984 The difficult choice of treatment for poorly controlled maturity-onset diabetes: tablets or insulin? Br Med J. 288:1956-1959.
15. Vessby B, Boberg M, Hellsing K, Lithell H, Berne C. 1989 C-peptide but not insulin concentrations are related to the serum lipoprotein levels during insulin treatment of non-insulin-dependent diabetes mellitus (NIDDM) patients. Diabetes Res. 12:109-116.
16. Bruce DG, Clark EM, Campbell LV, Chrisholm DJ. 1487 Insulin therapy in patients with poorly controlled non-insulin-dependent diabetes mellitus. Med J Aust. 146:240-242.
17. Reaven G. 1988 Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 37:1595-1607.
18. Yki-Järvinen H. 1992 Glucose toxicity. Endocr Rev. 13:415-431.
19. DeFronzo RA, Goodman AM. 1995 Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med. 333:541-549.
20. Lindström T, Eriksson P, Olsson AG, Arnqvist HJ. 1994 Long-term improvement of glycemic control by insulin treatment in NIDDM patients with secondary failure. Diabetes Care. 17:719-721.
21. Ferrannini E. 1992 The haemodynamics of obesity: a theoretical analysis. J Hypertens. 10:1417-1423.
22. Taylor R, Foster B, Kyne-Grzebalski D, Vanderpump M. 1994 Insulin regimens in the non-insulin dependent: impact on diurnal metabolic state and quality of life. Diabetes Med. 11:551-557.